Fragoso, Yara Dadalti <br/><br/>
Seroconversion of JCV antibodies is strongly associated to natalizumab therapy.  [electronic resource] 

 -  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia  Mar 2019 
 - 112-113 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-2653 
<br/><br/><label>Standard No.: </label>10.1016/j.jocn.2018.10.128  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Viral--immunology<br/>Brazil<br/>Female<br/>Humans<br/>Immunologic Factors--adverse effects<br/>JC Virus--immunology<br/>Male<br/>Multiple Sclerosis--drug therapy<br/>Natalizumab--adverse effects<br/>Seroconversion--drug effects